Mumbai: Sun Pharma Advanced Research Company Ltd. has announced submission of an Investigational New Drug (IND) application ...

SPARC seeks US FDA nod to start phase 1 trial of SBO-154 to treat advanced solid tumours: Our Bureau, Mumbai Monday, March 31, 2025, 12:15 Hrs [IST] Sun Pharma Advanced Research C ...

“SBO-154, our first ADC is ready to advance in phase 1 with this IND submission, and this is an important milestone for SPARC as we hope to improve lives of cancer patients globally.” said Anil ...

Relive the thrill of SBO Hengelo 2009! From high-speed battles to intense cornering, this event had it all. Watch the best moments from this unforgettable race day! 🏎️💨 ...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): Strategic Company Decision SBO presents recalibrated ...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): Annual Results Financial year 2024: SBO delivered solid ...

Experience the thrill of SBO Hengelo 2009 as bike #78 takes on the track! High-speed action, tight corners, and pure adrenaline—this is racing at its best! 🏁🔥 Trump buys red Tesla Model S ...

The Schroder British Opportunities (SBO) trust is proposing a major thesis shift to focus purely on private equities and end ...

For the first eight years of its life, the 24-inch was the sole telescope at SBO, and was kept busy seven nights a week with undergraduate observing sessions, graduate research, and public open houses ...

Sommers-Bausch Observatory (SBO) on the University of Colorado Boulder campus is operated by the Department of Astrophysical and Planetary Sciences (APS) to provide observational experience for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SBO-154, our first ADC is ready to advance in phase 1 with this IND submission, and this is an important milestone for SPARC as we hope to improve lives of cancer patients globally. said Anil Raghavan ...